Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects - PubMed (original) (raw)
Comparative Study
. 1993 Nov;36(11):1175-84.
doi: 10.1007/BF00401063.
Affiliations
- PMID: 8270133
- DOI: 10.1007/BF00401063
Comparative Study
Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects
M I Uusitupa et al. Diabetologia. 1993 Nov.
Abstract
The purpose of the present study was to examine 10-year cardiovascular morbidity and mortality in patients with newly-diagnosed Type 2 (non-insulin-dependent) diabetes mellitus and non-diabetic control subjects and to evaluate the effects of general risk factors, plasma insulin, urinary albumin excretion, lipoprotein abnormalities characteristic of Type 2 diabetes and the degree of hyperglycaemia in diabetic patients on cardiovascular mortality. Furthermore, the extent to which the above-mentioned factors could contribute to the excessive cardiovascular mortality observed in diabetic patients was examined. In the years 1979-1981, altogether 133 (70 men, 63 women) newly-diagnosed patients with Type 2 diabetes and 144 (62 men, 82 women) non-diabetic control subjects aged 45-64 years were studied. Both groups were re-examined in the years 1985-1986 and 1991-1992. The impact of different factors on cardiovascular mortality was examined by univariate analyses after adjustment for age and sex and by multiple logistic regression analyses. The age-standardized total and cardiovascular mortality rates were substantially higher in diabetic men (17.8 and 15.0%, total and cardiovascular mortality, respectively p = 0.06 and NS) and women (18.5 and 16.6%, p < 0.01 for both) than in non-diabetic control men (5.2% both total and cardiovascular mortality) and women (4.2 and 2.2%). Cardiovascular mortality was not related to the treatment modality (diet, oral drugs, insulin) at 5 years from diagnosis. Use of diuretics, beta-blocking agents or their combination at baseline did not make a significant contribution to cardiovascular mortality either. In multiple logistic regression analysis on diabetic patients, age, LDL triglycerides, smoking, blood glucose and ischaemic ECG at baseline had independent associations with cardiovascular mortality. Interestingly, urinary albumin excretion rate measured at 5-year examination also predicted 10-year cardiovascular mortality after adjustment for the effects of major risk factors including lipoprotein abnormalities, but its predictive power reduced to a nonsignificant level when the effect of plasma glucose was taken into account. The relative risk of cardiovascular mortality associated with diabetes was 8.2 after allowing for age alone, but it declined to 3.7 when all contributing factors from the baseline examination (except blood glucose) were taken into account. In conclusion, the present results indicate that LDL triglycerides and/or other changes in lipoprotein composition characteristic of Type 2 diabetes and manifesting as elevated serum triglycerides are atherogenic and they strongly predict increased cardiovascular mortality.(ABSTRACT TRUNCATED AT 400 WORDS)
Similar articles
- Hyperglycemia and compositional lipoprotein abnormalities as predictors of cardiovascular mortality in type 2 diabetes: a 15-year follow-up from the time of diagnosis.
Niskanen L, Turpeinen A, Penttilä I, Uusitupa MI. Niskanen L, et al. Diabetes Care. 1998 Nov;21(11):1861-9. doi: 10.2337/diacare.21.11.1861. Diabetes Care. 1998. PMID: 9802734 - Clustering of cardiovascular risk factors in type 2 diabetes mellitus: prognostic significance and tracking.
Kaukua J, Turpeinen A, Uusitupa M, Niskanen L. Kaukua J, et al. Diabetes Obes Metab. 2001 Feb;3(1):17-23. doi: 10.1046/j.1463-1326.2001.00093.x. Diabetes Obes Metab. 2001. PMID: 11213595 - Plasma lipoprotein abnormalities in type 1 (insulin-dependent) diabetes mellitus.
Dullaart RP. Dullaart RP. Neth J Med. 1995 Jan;46(1):44-54. doi: 10.1016/0300-2977(94)00048-e. Neth J Med. 1995. PMID: 7877714 Review. - Atherogenic profiles in insulin-dependent diabetic patients and their treatment.
De Leeuw I. De Leeuw I. Eur J Epidemiol. 1992 May;8 Suppl 1:125-8. doi: 10.1007/BF00145363. Eur J Epidemiol. 1992. PMID: 1505649 Review.
Cited by
- The effect of glycaemic control on the quantitative characteristics of retinopathy lesions in patients with type 2 diabetes mellitus: 10-year follow-up study.
Kalesnykiene V, Sorri I, Voutilainen R, Uusitupa M, Niskanen L, Uusitalo H. Kalesnykiene V, et al. Graefes Arch Clin Exp Ophthalmol. 2009 Mar;247(3):335-41. doi: 10.1007/s00417-008-1001-6. Epub 2008 Nov 29. Graefes Arch Clin Exp Ophthalmol. 2009. PMID: 19043734 - Evaluation of clinical activity and safety of Daflon 500 mg in type 2 diabetic female patients.
Rizk SM, Sabri NA. Rizk SM, et al. Saudi Pharm J. 2009 Jul;17(3):199-207. doi: 10.1016/j.jsps.2009.08.008. Epub 2009 Aug 7. Saudi Pharm J. 2009. PMID: 23964162 Free PMC article. - Impaired glucose tolerance and unidentified diabetes.
Heine RJ, Mooy JM. Heine RJ, et al. Postgrad Med J. 1996 Feb;72(844):67-71. doi: 10.1136/pgmj.72.844.67. Postgrad Med J. 1996. PMID: 8871454 Free PMC article. Review. - Ten-year mortality and cardiovascular morbidity in the Finnish Diabetes Prevention Study--secondary analysis of the randomized trial.
Uusitupa M, Peltonen M, Lindström J, Aunola S, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Valle TT, Eriksson JG, Tuomilehto J; Finnish Diabetes Prevention Study Group. Uusitupa M, et al. PLoS One. 2009 May 21;4(5):e5656. doi: 10.1371/journal.pone.0005656. PLoS One. 2009. PMID: 19479072 Free PMC article. Clinical Trial. - Is it possible to predict diabetic kidney disease?
Thomas SM, Viberti GC. Thomas SM, et al. J Endocrinol Invest. 2000 Jan;23(1):44-53. doi: 10.1007/BF03343676. J Endocrinol Invest. 2000. PMID: 10698052 Review. No abstract available.
References
- Diabetes. 1989 Jan;38(1):117-22 - PubMed
- Diabetes Res Clin Pract. 1993 Mar;19(3):227-38 - PubMed
- Diabetologia. 1989 Apr;32(4):219-26 - PubMed
- Diabetes Care. 1990 Jan;13(1):41-8 - PubMed
- Horm Metab Res Suppl. 1985;15:46-51 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Miscellaneous